Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Palliat Support Care. 2020 Jun;18(3):322–331. doi: 10.1017/S1478951519000920

Table 1.

Demographic and treatment characteristics of 470 adult retinoblastoma survivors

Variable Overall
(n = 404)
Unilateral
(n = 190)
Bilateral
(n = 214)
Age at study
Median (range) 44 (18, 77) 44.5 (19, 77) 43 (18, 69)
Mean (SD) 44.0 (11) 44.6 (10.6) 43.5 (10.4)
Gender
Male 186 (46) 81 (42.6) 105 (49.1)
Female 218 (54) 109 (57.4) 109 (50.9)
INSURANCE
No 45 (11.1) 28 (14.7) 17 (7.9)
Yes, or Canadian resident 357 (88.4) 161 (84.7) 196 (91.6)
NA 2 (0.5) 1 (0.5) 1 (0.5)
INCOME
< $20,000/year 36 (8.9) 10 (5.3) 26 (12.1)
≥ $20,000/year 340 (84.2) 166 (87.4) 174 (81.3)
Don’t know/missing 28 (6.9) 14 (7.4) 14 (6.5)
COLLEGE
Complete high school or less 57 (14.1) 25 (13.2) 32 (15)
Post-high school graduate or some college training 336 (83.2) 160 (84.2) 176 (82.2)
Unknown/Missing 11 (2.7) 5 (2.6) 6 (2.8)
Radiation Therapy
Yes 213 (52.7) 18 (9.5) 195 (91.1)
No 188 (46.5) 170 (89.5) 18 (8.4)
Unknown/Missing 3 (0.7) 2 (1.1) 1 (0.5)
Chemotherapy
Yes 112 (27.7) 22 (11.6) 90 (42.1)
No 289 (71.5) 165 (86.8) 124 (57.9)
Unknown/Missing 3 (0.7) 3 (1.6) 0 (0)
Surgery
Bilateral enucleation 54 (13.4) 0 (0) 54 (25.2)
Unilateral enucleation 350 (86.6) 190 (100) 160 (74.8)